Market Cap 111.51M
Revenue (ttm) 13.86M
Net Income (ttm) -79.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -574.46%
Debt to Equity Ratio 0.00
Volume 437,500
Avg Vol 537,046
Day's Range N/A - N/A
Shares Out 63.36M
Stochastic %K 67%
Beta 1.42
Analysts Strong Sell
Price Target $6.89

Company Profile

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; PYX-102, an investigational immunotherapeutic targeting KLRG1, an inhibitory receptor on T cells and NK cells, with potential for use as monothera...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 453 3596
Address:
321 Harrison Avenue, 11th Floor, Suite 1, Boston, United States
StockScanners
StockScanners Jun. 6 at 10:59 PM
$PYXS 1.75 is the area that stands out on this chart. What's interesting is how price is approaching a level that appears increasingly relevant from a structural standpoint. Markets often provide their clearest signals when they begin repeatedly acknowledging the same area. The reaction around 1.75 may reveal more about the underlying trend than the headline move itself. Curious if others have 1.75 marked, or if a different level has your attention.
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Jun. 5 at 5:16 PM
$PYXS I chose wisely 😁
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Jun. 5 at 2:29 PM
$PYXS I’m starting to nibble …mid 1.60’s
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 3 at 1:21 PM
0 · Reply
Lacey297
Lacey297 May. 27 at 5:33 AM
$PYXS what happened today any news ? Been on the sidelines but been watching not sure now i want to pull the trigger
1 · Reply
Bullbear1010101
Bullbear1010101 May. 27 at 1:12 AM
$PYXS wow down .33
0 · Reply
Adnan_
Adnan_ May. 26 at 7:12 PM
$PYXS Where‘s the Voluuumwee I wanna buyy
0 · Reply
LabPsycho
LabPsycho May. 15 at 7:24 PM
$PYXS @Relee187200 IMO, on explanation might be market makers sucked out the quick money up 100% in weeks taking out their stop loss orders, then cueing up for the next pump before the money raise?
0 · Reply
Relee187200
Relee187200 May. 14 at 2:32 PM
$PYXS What the hell is going on??
1 · Reply
LabPsycho
LabPsycho May. 14 at 1:56 PM
$PYXS IMO, seems like they are running low on cash + the curiously timed $350M mixed shelf offering last November + the 100% gain in a few recent weeks suggests to me room to retrace further.
1 · Reply
Latest News on PYXS
Pyxis Oncologyreports Q1 EPS (37c), consensus (35c)

2026-05-14T13:11:04.000Z - 4 weeks ago

Pyxis Oncologyreports Q1 EPS (37c), consensus (35c)


Pyxis Oncology Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 4 weeks ago

Pyxis Oncology Quarterly report: Q1 2026


Pyxis Oncology Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 4 weeks ago

Pyxis Oncology Earnings release: Q1 2026


Pyxis Oncology to Participate in Upcoming Investor Conferences

May 13, 2026, 7:30 AM EDT - 4 weeks ago

Pyxis Oncology to Participate in Upcoming Investor Conferences


Pyxis Oncology Slides: Investor presentation

May 13, 2026, 7:00 AM EDT - 4 weeks ago

Pyxis Oncology Slides: Investor presentation


Pyxis Oncology initiated with an Outperform at Wedbush

2026-05-05T11:30:55.000Z - 5 weeks ago

Pyxis Oncology initiated with an Outperform at Wedbush


Pyxis Oncology Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 6 weeks ago

Pyxis Oncology Proxy statement: Proxy filing


Pyxis Oncology Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 6 weeks ago

Pyxis Oncology Proxy statement: Proxy filing


Pyxis Oncology price target lowered to $8 from $9 at Stifel

2026-03-24T10:51:42.000Z - 2 months ago

Pyxis Oncology price target lowered to $8 from $9 at Stifel


Pyxis Oncology Earnings release: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 2 months ago

Pyxis Oncology Earnings release: Q4 2025


Pyxis Oncology Annual report: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 2 months ago

Pyxis Oncology Annual report: Q4 2025


Pyxis Oncology Slides: Corporate presentation

Mar 23, 2026, 7:00 AM EDT - 2 months ago

Pyxis Oncology Slides: Corporate presentation


Pyxis Oncology Transcript: Study Update

Dec 18, 2025, 8:30 AM EST - 6 months ago

Pyxis Oncology Transcript: Study Update


Pyxis Oncology Press release: Study Update

Dec 18, 2025, 8:30 AM EST - 6 months ago

Pyxis Oncology Press release: Study Update


Pyxis Oncology Slides: Study Update

Dec 18, 2025, 8:30 AM EST - 6 months ago

Pyxis Oncology Slides: Study Update


Pyxis Oncology sees cash runway into 4Q26

2025-12-18T12:17:22.000Z - 6 months ago

Pyxis Oncology sees cash runway into 4Q26


Pyxis Oncology files $350M mixed securities shelf

2025-11-26T14:15:39.000Z - 7 months ago

Pyxis Oncology files $350M mixed securities shelf


Pyxis Oncology Registration statement: Registration Filing

Nov 26, 2025, 7:00 AM EST - 7 months ago

Pyxis Oncology Registration statement: Registration Filing


Pyxis Oncology price target raised to $8 from $5 at Stephens

2025-11-24T12:35:39.000Z - 7 months ago

Pyxis Oncology price target raised to $8 from $5 at Stephens


Pyxis Oncology Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 4:00 PM EST - 7 months ago

Pyxis Oncology Transcript: Stifel 2025 Healthcare Conference


Pyxis Oncology Quarterly report: Q3 2025

Nov 3, 2025, 4:00 PM EST - 7 months ago

Pyxis Oncology Quarterly report: Q3 2025


Pyxis Oncology reports Q3 EPS (35c), consensus (34c)

2025-11-03T12:12:11.000Z - 7 months ago

Pyxis Oncology reports Q3 EPS (35c), consensus (34c)


Pyxis Oncology resumed with a Buy at Stifel

2025-11-03T11:51:01.000Z - 7 months ago

Pyxis Oncology resumed with a Buy at Stifel


Pyxis Oncology appoints Alex Kane as SVP, IR, capital markets

2025-10-09T11:35:39.000Z - 8 months ago

Pyxis Oncology appoints Alex Kane as SVP, IR, capital markets


Pyxis Oncology initiated with a Buy at Guggenheim

2025-09-04T09:40:07.000Z - 10 months ago

Pyxis Oncology initiated with a Buy at Guggenheim


Pyxis Oncology initiated with a Buy at Guggenheim

2025-09-03T20:31:05.000Z - 10 months ago

Pyxis Oncology initiated with a Buy at Guggenheim


Pyxis Oncology reports Q2 EPS (30c), consensus (35c)

2025-08-14T20:15:50.000Z - 10 months ago

Pyxis Oncology reports Q2 EPS (30c), consensus (35c)


Pyxis Oncology Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Pyxis Oncology Earnings release: Q2 2025


Pyxis Oncology Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Pyxis Oncology Quarterly report: Q2 2025


Crescent Biopharma appoints Jan Pinkas as CSO

2025-07-08T11:36:10.000Z - 1 year ago

Crescent Biopharma appoints Jan Pinkas as CSO

CBIO


Pyxis Oncology Slides: Corporate Presentation

May 16, 2025, 7:00 AM EDT - 1 year ago

Pyxis Oncology Slides: Corporate Presentation


Pyxis Oncology Earnings release: Q1 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Pyxis Oncology Earnings release: Q1 2025


Pyxis Oncology Quarterly report: Q1 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Pyxis Oncology Quarterly report: Q1 2025


Pyxis Oncology Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Annual report: Q4 2024

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Pyxis Oncology Annual report: Q4 2024


Pyxis Oncology Earnings release: Q4 2024

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Pyxis Oncology Earnings release: Q4 2024


Pyxis Oncology Transcript: Status Update

Nov 20, 2024, 4:30 PM EST - 1 year ago

Pyxis Oncology Transcript: Status Update


Pyxis Oncology Slides: Status Update

Nov 20, 2024, 4:30 PM EST - 1 year ago

Pyxis Oncology Slides: Status Update


Pyxis Oncology Quarterly report: Q3 2024

Nov 18, 2024, 7:00 AM EST - 1 year ago

Pyxis Oncology Quarterly report: Q3 2024


Pyxis Oncology Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 1 year ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Proxy statement: Proxy Filing

Sep 13, 2024, 8:00 AM EDT - 1 year ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Quarterly report: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 1 year ago

Pyxis Oncology Quarterly report: Q2 2024


Pyxis Oncology Earnings release: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 1 year ago

Pyxis Oncology Earnings release: Q2 2024


Pyxis Oncology Slides: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 1 year ago

Pyxis Oncology Slides: Q2 2024


Pyxis Oncology Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Pyxis Oncology Quarterly report: Q1 2024


Pyxis Oncology Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Pyxis Oncology Earnings release: Q1 2024


Pyxis Oncology Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Registration statement: Registration Filing

Mar 27, 2024, 8:00 AM EDT - 2 years ago

Pyxis Oncology Registration statement: Registration Filing


Pyxis Oncology Annual report: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Pyxis Oncology Annual report: Q4 2023


Pyxis Oncology Earnings release: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Pyxis Oncology Earnings release: Q4 2023


Pyxis Oncology Slides: Corporate Presentation

Dec 19, 2023, 12:50 PM EST - 2 years ago

Pyxis Oncology Slides: Corporate Presentation


Pyxis Oncology Quarterly report: Q3 2023

Nov 7, 2023, 7:00 AM EST - 2 years ago

Pyxis Oncology Quarterly report: Q3 2023


Pyxis Oncology Earnings release: Q3 2023

Nov 7, 2023, 7:00 AM EST - 2 years ago

Pyxis Oncology Earnings release: Q3 2023


Pyxis Oncology Successfully Completes Acquisition of Apexigen

Aug 23, 2023, 8:35 AM EDT - 3 years ago

Pyxis Oncology Successfully Completes Acquisition of Apexigen


Pyxis Oncology Quarterly report: Q2 2023

Aug 11, 2023, 7:00 AM EDT - 3 years ago

Pyxis Oncology Quarterly report: Q2 2023


Pyxis Oncology Earnings release: Q2 2023

Aug 11, 2023, 7:00 AM EDT - 3 years ago

Pyxis Oncology Earnings release: Q2 2023


Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs

May 30, 2023, 8:30 AM EDT - 3 years ago

Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs


Pyxis Oncology Transcript: M&A Announcement

May 24, 2023, 7:01 AM EDT - 3 years ago

Pyxis Oncology Transcript: M&A Announcement


Pyxis Oncology Press release: M&A Announcement

May 24, 2023, 7:01 AM EDT - 3 years ago

Pyxis Oncology Press release: M&A Announcement


Pyxis Oncology Slides: M&A Announcement

May 24, 2023, 7:01 AM EDT - 3 years ago

Pyxis Oncology Slides: M&A Announcement


Pyxis Oncology to Acquire Apexigen

May 24, 2023, 6:45 AM EDT - 3 years ago

Pyxis Oncology to Acquire Apexigen


Pyxis Oncology Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Pyxis Oncology Proxy statement: Proxy Filing


Pyxis Oncology Annual report: Q4 2022

Mar 22, 2023, 6:46 AM EDT - 3 years ago

Pyxis Oncology Annual report: Q4 2022


StockScanners
StockScanners Jun. 6 at 10:59 PM
$PYXS 1.75 is the area that stands out on this chart. What's interesting is how price is approaching a level that appears increasingly relevant from a structural standpoint. Markets often provide their clearest signals when they begin repeatedly acknowledging the same area. The reaction around 1.75 may reveal more about the underlying trend than the headline move itself. Curious if others have 1.75 marked, or if a different level has your attention.
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Jun. 5 at 5:16 PM
$PYXS I chose wisely 😁
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Jun. 5 at 2:29 PM
$PYXS I’m starting to nibble …mid 1.60’s
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 3 at 1:21 PM
0 · Reply
Lacey297
Lacey297 May. 27 at 5:33 AM
$PYXS what happened today any news ? Been on the sidelines but been watching not sure now i want to pull the trigger
1 · Reply
Bullbear1010101
Bullbear1010101 May. 27 at 1:12 AM
$PYXS wow down .33
0 · Reply
Adnan_
Adnan_ May. 26 at 7:12 PM
$PYXS Where‘s the Voluuumwee I wanna buyy
0 · Reply
LabPsycho
LabPsycho May. 15 at 7:24 PM
$PYXS @Relee187200 IMO, on explanation might be market makers sucked out the quick money up 100% in weeks taking out their stop loss orders, then cueing up for the next pump before the money raise?
0 · Reply
Relee187200
Relee187200 May. 14 at 2:32 PM
$PYXS What the hell is going on??
1 · Reply
LabPsycho
LabPsycho May. 14 at 1:56 PM
$PYXS IMO, seems like they are running low on cash + the curiously timed $350M mixed shelf offering last November + the 100% gain in a few recent weeks suggests to me room to retrace further.
1 · Reply
focafoca99
focafoca99 May. 14 at 12:03 PM
$PYXS issued its Q1 2026 earnings, reporting results for the quarter ended March 31, 2026.
0 · Reply
StockScanners
StockScanners May. 9 at 4:04 PM
$PYXS keep watch if this holds above 2.43
0 · Reply
FonsieTrader
FonsieTrader May. 9 at 2:00 PM
$PYXS 👀 This one is trying to reclaim momentum after a brutal reset… and the chart is starting to wake up again. The Technicals: ✅ Strong bounce from the $1.20–1.30 zone ✅ Reclaiming key resistance around $2.15 ✅ TTM Squeeze momentum curling back up ✅ MFI pushing above 80 → aggressive money flow ✅ Volume expanding on breakout candles ✅ OBV stabilizing → selling pressure fading Key level now: $2.15 If bulls hold above that zone, this could quickly push toward the $3.80–5.00 range again. Biotech microcaps move FAST once momentum returns. This looks like the beginning of a new expansion phase.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 8 at 2:20 PM
$PYXS I told u there it was going... This is what I do for my peeps in the Pitt 🌞 🌞 this was a freebie... Good luck 🫡
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 8 at 1:47 PM
$PYXS Did u add with me??? Here comes $2.50... Another overnight swing winner.. We are on fire 🔥 🔥
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 7 at 1:35 PM
$PYXS Adds! In the gap... $2.50 Or more no reason why not imo🚨🚨
0 · Reply
Ron_Burn
Ron_Burn May. 7 at 2:02 AM
$PYXS good performance today
0 · Reply
StockScanners
StockScanners May. 7 at 12:33 AM
$PYXS keep watch if this holds above 2.21
0 · Reply
ElectricEel86
ElectricEel86 May. 6 at 9:35 PM
$PYXS wow!! Def bullish
0 · Reply
topstockalerts
topstockalerts May. 6 at 8:02 PM
$PYXS been waiting for this one to move… finally happening
0 · Reply
Youngmoney22choppa
Youngmoney22choppa May. 6 at 7:33 PM
0 · Reply
MadMaverick
MadMaverick May. 6 at 7:24 PM
🚨$GANX - Parkinson's drug GT-02287 just wrapped Phase 1b. Here's what the data shows: 21 patients enrolled. 19 completed 90 days. 84% of eligible patients voluntarily chose to continue into the 9-month extension. You don't stay in a trial if it's not working. ✅Extension ongoing until Q3 2026 → 16 patients. Results coming. ✅Safety, tolerability + biomarker signal in Parkinson's patients with or without GBA1 mutation. ✅First-in-human already confirmed GCase target engagement. Phase 2 launch targeted Q3 2026. 4 analysts. All Strong Buy. $7.50 price target. The extension retention rate tells the story. Communicated Disclaimer - DYOR too. https://chartingdaily.com/structural-health Other biotech stocks running up today: $PYXS $AVTX $ERNA
2 · Reply